bioaccess®: LATAM CRO Experts

View Original

IAOCR and bioaccess® Partner to Bring First-Ever Clinical Research Accreditation to Latin America

Groundbreaking collaboration set to elevate quality standards and competitiveness in the region's clinical research industry

FOR IMMEDIATE RELEASE

Miami, FL - November 30, 2024 - In a landmark move for Latin America's clinical research sector, the International Academy of Clinical Research (IAOCR) and bioaccess® today announced a strategic partnership to introduce the region's first-ever certification and accreditation program for clinical research sites and professionals. This collaboration marks a significant milestone in the industry's history, promising to align Latin American clinical research practices with international quality standards.

The partnership between IAOCR, a global leader in clinical research accreditation, and bioaccess®, a renowned contract research organization (CRO) specializing in Latin America, addresses a critical need in the region's rapidly growing clinical research landscape. For the first time, clinical research sites and professionals in Latin America will have access to a comprehensive certification (for research sites) and accreditation (for research professionals) program designed to:

  • Elevate quality standards across the industry

  • Provide international recognition for local expertise

  • Enhance competitiveness in the global market

  • Standardize best practices in clinical research

This partnership with bioaccess® is a game-changer for clinical research in Latin America. By bringing IAOCR's well-known accreditation to the region, IAOCR and bioaccess® are raising standards. They are also helping Latin American researchers show their skills to the world.

Julio G. Martinez-Clark, CEO of bioaccess®, echoed this sentiment: "Our collaboration with IAOCR represents a pivotal moment for clinical research in Latin America. This accreditation program will empower our local talent, attract more clinical trials to the region, and ultimately contribute to better healthcare outcomes for our populations."

The accrediation program, launching with immediate effect, will cover a wide range of competencies crucial for conducting high-quality clinical trials. It will be available to research sites, investigators, coordinators, and other professionals involved in clinical research across Latin America. Key benefits of the accreditation include:

  • Quality Improvement: Standardized training and assessment to ensure consistent, high-quality research practices

  • International Recognition: A globally acknowledged accreditation that validates the expertise of Latin American research professionals

  • Increased Competitiveness: Enhanced ability to attract and participate in global clinical trials

  • Standardized Practices: Implementation of internationally recognized best practices in clinical research

This initiative is expected to significantly impact the clinical research landscape in Latin America, potentially attracting more investment, increasing the number of clinical trials conducted in the region, and improving patient access to cutting-edge treatments.

For more information about the accreditation program or to inquire about enrollment, please contact bioaccess®.

About IAOCR: The International Academy of Clinical Research (IAOCR) is a leading provider of accreditation and certification for the clinical research industry. With a global presence, IAOCR is dedicated to enhancing the quality and efficiency of clinical trials through standardized competence-based accreditation. Read more about IAOCR at https://iaocr.com/.

About bioaccess®: bioaccess® is a US-based Medtech contract research organization (CRO) that delivers full-service clinical development services to international medical device companies. Specializing in Latin America, bioaccess® is committed to accelerating clinical research while maintaining the highest quality standards. Read more about bioaccess® at https://www.bioaccessla.com/.

Media Contact: Sharick Rubio, marketing director, srubio@bioaccessla.com, +1 (305) 539-9106‬